ヘリコバクターピロリ診断市場レポート：2030年までの動向、予測、競合分析

ヘリコバクターピロリ診断の動向と予測

世界のヘリコバクターピロリ診断市場の将来は、病院、診断研究所、クリニック市場での機会により有望視されています。世界のヘリコバクターピロリ診断市場は、2024年から2030年にかけてCAGR 4.8%で成長すると予測されます。この市場の主な促進要因は、個別の抗生物質治療に対するニーズの高まり、感染症の増加、感染症に関する知識の高まり、ヘリコバクターピロリ感染検出の費用対効果の向上です。

• Lucintel社では、タイプ別では、新しい技術的進歩を必要とする胃疾患の発生が増加しているため、予測期間中、試薬が最大のセグメントであり続けると予測しています。
• この市場において、最終用途カテゴリーでは、十二指腸潰瘍、胃がん、胃炎、胃潰瘍のような疾患の発生率の増加により、病院が最大のセグメントであり続けると思われます。
• 地域別では、医療インフラの整備、FDA、NIH、CDCなどの機関による措置、新興経済諸国の存在により、北米が予測期間中に最も高い成長を示すと予想されます。

ヘリコバクターピロリ診断市場の戦略的成長機会

ヘリコバクターピロリ診断市場は、未治療の感染に伴う健康リスクに対する意識の高まりと、高度な診断技術の利用可能性の向上により、大きな成長機会をもたらしています。世界のヘルスケアシステムが胃疾患の早期発見と予防を優先する中、この成長市場において企業が提供する製品を拡大する大きな可能性があります。新興技術を活用し、新たな地域に進出することで、企業はこれまで十分なサービスを受けていなかった市場を開発し、患者の予後を改善することができます。

• 非侵襲的診断薬の拡大：呼気検査や便中抗原検査など、非侵襲的診断法の開発と販売に注力する企業は、その人気の高まりに乗じることができます。
• 新興市場：医療インフラが改善しつつあり、胃疾患の負担が依然として大きいアジア、アフリカ、ラテンアメリカの新興市場には、事業拡大の大きなチャンスがあります。
• 個別化診断と治療：遺伝的変異や抗菌薬耐性パターンを考慮した診断を含む個別化医療への動きは、新たな成長の道を提供します。
• 遠隔医療およびデジタルヘルスとの統合：診断検査を遠隔医療プラットフォームと統合することで、特に遠隔地における患者の医療アクセスを強化し、診断薬企業に新たな機会をもたらします。
• ヘルスケアプロバイダーとのパートナーシップ：総合的な診断・治療ソリューションを開発するための病院、診療所、製薬会社との戦略的パートナーシップは、市場の成長を後押しします。

ピロリ菌診断市場における戦略的成長機会は豊富であり、特に非侵襲的診断法の拡大、新興市場のターゲット化、個別化医療の統合に注力する企業にとって重要です。ヘルスケアプロバイダーとの提携や遠隔医療プラットフォームの活用も、市場へのリーチと患者の治療へのアクセスを強化します。これらの機会を活用することで、企業は急成長するピロリ菌診断市場におけるリーダーとしての地位を確立することができます。

ヘリコバクターピロリ診断市場の促進要因・課題

ヘリコバクターピロリ診断市場は、ピロリ菌感染がもたらす健康リスクに対する認識の高まりや、正確で非侵襲的な診断ツールに対する需要の高まりなど、様々な要因の影響を受けています。しかし、市場は規制のハードル、検査の複雑さ、市場競争などの課題にも直面しています。ピロリ菌診断の競合情勢と進化で成功を目指す利害関係者にとって、促進要因と課題の両方を理解することは不可欠です。

市場促進要因：

• 胃疾患の有病率の増加：ピロリ菌感染に関連した胃潰瘍、胃炎、胃がんの罹患率の上昇が診断検査需要を牽引しています。
• 非侵襲的検査へのシフト：呼気抗原検査や便中抗原検査などの非侵襲的検査は、その使いやすさと患者の快適性の向上により支持を集めています。
• ピロリ菌リスクに対する意識の高まり：胃疾患におけるピロリ菌の役割に対する認識が高まるにつれ、早期発見と効果的な治療に対する需要も高まっています。
• 診断における技術の進歩：PCRや次世代シークエンシングなど、分子診断学における継続的な技術革新により、ピロリ菌の検出はより迅速、より正確、より低侵襲になりつつあります。
• ヘルスケアインフラの整備：新興国市場における成長機会：発展途上地域におけるヘルスケア・インフラの拡充により、診断ツールへのアクセスが向上しています。

市場の課題

• 規制上の障壁：新しい診断検査に対する規制当局の承認プロセスは複雑で時間がかかるため、革新的なソリューションの市場投入に時間がかかります。
• 先端診断薬のコスト：特に低所得地域や予算が限られているヘルスケア環境では、高度診断技術に関連する高コストが普及を制限する可能性があります。
• 診断精度と偽陽性：進歩にもかかわらず、一部の診断法は依然として精度に問題があり、偽陽性や偽陰性を引き起こし、患者管理を複雑にする可能性があります。

ピロリ菌診断市場は、早期発見に対する需要の高まり、非侵襲的検査へのシフト、診断技術の進歩によって牽引されています。しかし、規制上のハードル、コスト面、他の検査法との競合といった課題も残されています。これらの課題に対処し、主要な市場促進要因を活用することで、企業は進化する状況を乗り切り、この重要な胃腸の健康分野における成長機会をつかむことができます。

目次

第1章 エグゼクティブサマリー

第2章 世界のヘリコバクターピロリ診断市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のヘリコバクターピロリ診断市場の動向（2018～2023年）と予測（2024～2030年）
• ヘリコバクターピロリ診断市場：タイプ別
  • 機器
  • 試薬
  • サービス
• ヘリコバクターピロリ診断の世界市場：技術別
  • 免疫測定
  • POC検査
  • 分子診断
• ヘリコバクターピロリ診断市場の世界規模：最終用途別
  • 病院
  • 診断研究所
  • クリニック

第4章 2018年から2030年までの地域別市場動向と予測分析

• 地域別ヘリコバクターピロリ診断市場
• 北米のヘリコバクターピロリ診断市場
• 欧州のヘリコバクターピロリ診断市場
• アジア太平洋地域のヘリコバクターピロリ診断市場
• その他地域のヘリコバクターピロリ診断市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界のヘリコバクターピロリ診断市場のタイプ別成長機会
  • 世界のヘリコバクターピロリ診断市場の技術別成長機会
  • 世界のヘリコバクターピロリ診断市場の最終用途別成長機会
  • 世界のヘリコバクターピロリ診断市場の地域別成長機会
• 世界のヘリコバクターピロリ診断市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界のヘリコバクターピロリ診断市場の能力拡大
  • 世界のヘリコバクターピロリ診断市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Thermo Fisher Scientific
• Biohit
• Quest Diagnostics
• Meridian Bioscience
• Bio-Rad Laboratories
• Alpha Laboratories
• F. Hoffmann-La Roche
• Coris BioConcept
• Certest Biotec
• Epitope Diagnostics

Helicobacter Pylori Diagnostic Trends and Forecast

The future of the global helicobacter pylori diagnostic market looks promising with opportunities in the hospital, diagnostic laboratory, and clinic markets. The global helicobacter pylori diagnostic market is expected to grow with a CAGR of 4.8% from 2024 to 2030. The major drivers for this market are the growing need for individualized antibiotic treatment, the increase of infectious illnesses, as well as, rising knowledge of infections and enhanced cost-effectiveness of helicobacter pylori infection detection.

• Lucintel forecasts that, within the type category, reagents will remain the largest segment over the forecast period due to increasing occurrences of gastric diseases necessitating new technological advancements.
• Within this market, within the end-use category, hospitals will remain the largest segment due to the increasing incidence of conditions like duodenal ulcers, stomach cancer, gastritis, and gastric ulcers.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to the creation of the healthcare infrastructure, actions taken by agencies like the FDA, NIH, and CDC, and the existence of developed economies.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Helicobacter Pylori Diagnostic Market

The Helicobacter pylori (H. pylori) diagnostic market has been experiencing significant transformations due to new technologies, improved diagnostic methods, and evolving healthcare needs. With H. pylori being a major cause of gastric ulcers and a key risk factor for gastric cancer, the demand for rapid, accurate, and non-invasive diagnostic tools continues to rise. Emerging trends in this field focus on enhancing test accuracy, speed, and patient convenience, while also reducing costs and improving accessibility to diagnostics in underserved regions.

• Advancements in Non-Invasive Testing: There is a growing adoption of non-invasive testing methods such as breath tests and stool antigen tests, which provide quicker and more comfortable alternatives to invasive biopsy procedures.
• Integration of Point-of-Care (POC) Testing: The development of portable, easy-to-use POC diagnostic devices is making H. pylori testing more accessible, especially in remote or rural areas.
• Rise of Molecular Diagnostics: Molecular techniques, such as PCR-based tests, are gaining popularity for their high sensitivity and accuracy in detecting H. pylori, particularly in complex or hard-to-diagnose cases.
• Focus on Personalized Medicine: Tailoring diagnostic tests to individual patient's needs, such as genetic susceptibility and antimicrobial resistance patterns, is becoming a key trend in H. pylori diagnostics.
• Increasing Use of Artificial Intelligence (AI): AI and machine learning algorithms are being integrated into diagnostic platforms to improve the speed and accuracy of H. pylori detection and interpretation of results.

Emerging trends in the H. pylori diagnostic market indicate a shift toward non-invasive, rapid, and highly accurate diagnostic methods, with a strong focus on accessibility and cost-effectiveness. Advances in molecular diagnostics, point-of-care devices, and AI integration will drive the next generation of H. pylori diagnostic tools. These innovations are set to significantly improve patient outcomes and expand the availability of diagnostic services globally, particularly in underserved regions.

Recent Developments in the Helicobacter Pylori Diagnostic Market

Recent developments in the Helicobacter pylori diagnostic market reflect a growing emphasis on improving the accuracy, speed, and patient experience in detecting H. pylori infections. Advances in testing technology, along with the increasing recognition of the link between H. pylori and various gastric diseases, are driving growth in the diagnostic sector. This section highlights key innovations and trends that are shaping the future of H. pylori diagnosis.

• Introduction of Advanced Breath Tests: The development of more sophisticated and accurate breath tests, such as those using isotope-labeled carbon, has improved the non-invasive detection of H. pylori infection.
• Novel Stool Antigen Tests: New, more sensitive stool antigen tests are improving diagnostic accuracy and are now being adopted for both initial diagnosis and post-treatment monitoring of H. pylori infections.
• Increased Focus on Rapid Diagnostic Kits: The market has seen the emergence of rapid diagnostic kits that provide quick results, reducing the need for laboratory-based analysis and enhancing patient convenience.
• AI-Assisted Diagnostics: Machine learning algorithms are increasingly being applied to assist in interpreting diagnostic results, improving both the accuracy and speed of diagnosing H. pylori infections.
• Collaborations with Research Institutions: Strategic collaborations between diagnostic companies and research institutions are facilitating the development of next-generation diagnostic tools, including tests that can identify antimicrobial resistance in H. pylori strains.

Recent developments in the H. pylori diagnostic market are largely driven by advancements in non-invasive testing technologies, including breath and stool antigen tests, as well as the integration of AI and machine learning into diagnostic platforms. These innovations not only enhance diagnostic accuracy and speed but also improve the patient experience. As the demand for quick and reliable H. pylori testing grows, the market is likely to see continued progress in both technology and accessibility.

Strategic Growth Opportunities for Helicobacter Pylori Diagnostic Market

The helicobacter pylori diagnostic market presents significant growth opportunities, driven by rising awareness of the health risks associated with untreated infections and the increasing availability of advanced diagnostic technologies. As global healthcare systems prioritize early detection and prevention of gastric diseases, there is substantial potential for companies to expand their offerings in this growing market. By leveraging emerging technologies and expanding into new regions, companies can tap into previously underserved markets and improve patient outcomes.

• Expansion of Non-Invasive Diagnostics: Companies focusing on the development and distribution of non-invasive diagnostic methods, such as breath tests and stool antigen tests, can capitalize on their growing popularity.
• Emerging Markets: There is a strong opportunity for expansion into emerging markets in Asia, Africa, and Latin America, where healthcare infrastructure is improving and the burden of gastric diseases remains high.
• Personalized Diagnostics and Treatment: The move toward personalized medicine, including diagnostics that take into account genetic variations and antimicrobial resistance patterns, offers new avenues for growth.
• Integration with Telemedicine and Digital Health: Integrating diagnostic tests with telemedicine platforms can enhance patient access to care, especially in remote areas, and create new business opportunities for diagnostic companies.
• Partnerships with Healthcare Providers: Strategic partnerships with hospitals, clinics, and pharmaceutical companies to develop comprehensive diagnostic and treatment solutions can boost market growth.

Strategic growth opportunities in the H. pylori diagnostic market are abundant, particularly for companies that focus on expanding non-invasive diagnostics, targeting emerging markets, and integrating personalized medicine. Collaborations with healthcare providers and leveraging telemedicine platforms will also enhance market reach and patient access to care. By capitalizing on these opportunities, companies can position themselves as leaders in the rapidly growing H. pylori diagnostic market.

Helicobacter Pylori Diagnostic Market Driver and Challenges

The helicobacter pylori diagnostic market is influenced by various factors, including the growing recognition of the health risks posed by H. pylori infections and the increasing demand for accurate and non-invasive diagnostic tools. However, the market also faces challenges, such as regulatory hurdles, the complexity of testing, and market competition. Understanding both the drivers and challenges is essential for stakeholders aiming to succeed in the competitive and evolving landscape of H. pylori diagnostics.

Market Drivers:

• Increased Prevalence of Gastric Diseases: The rising incidence of gastric ulcers, gastritis, and gastric cancer linked to H. pylori infections is driving the demand for diagnostic testing.
• Shift Toward Non-Invasive Testing: Non-invasive tests, such as breath and stool antigen tests, are gaining traction due to their ease of use and improved patient comfort.
• Growing Awareness of H. pylori Risks: As awareness about the role of H. pylori in gastric diseases increases, so does the demand for early detection and effective treatment.
• Technological Advancements in Diagnostics: Ongoing innovations in molecular diagnostics, such as PCR and next-generation sequencing, are making H. pylori detection faster, more accurate, and less invasive.
• Healthcare Infrastructure Development: Expanding healthcare infrastructure in developing regions is increasing access to diagnostic tools, creating growth opportunities in underserved markets.

Market Challenges:

• Regulatory Barriers: Regulatory approval processes for new diagnostic tests can be complex and time-consuming, slowing the time to market for innovative solutions.
• Cost of Advanced Diagnostics: High costs associated with advanced diagnostic technologies may limit adoption, particularly in low-income regions or healthcare settings with limited budgets.
• Diagnosis Accuracy and False Positives: Despite advances, some diagnostic methods still struggle with accuracy, leading to false positives or false negatives, which can complicate patient management.

The H. pylori diagnostic market is driven by increasing demand for early detection, the shift toward non-invasive testing, and advancements in diagnostic technology. However, challenges such as regulatory hurdles, cost considerations, and competition from other testing methods remain. By addressing these challenges and capitalizing on key market drivers, companies can navigate the evolving landscape and seize opportunities for growth in this important area of gastrointestinal health.

List of Helicobacter Pylori Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies helicobacter pylori diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the helicobacter pylori diagnostic companies profiled in this report include-

• Thermo Fisher Scientific
• Biohit
• Quest Diagnostics
• Meridian Bioscience
• Bio-Rad Laboratories
• Alpha Laboratories
• F. Hoffmann-La Roche
• Coris BioConcept
• Certest Biotec
• Epitope Diagnostics

Helicobacter Pylori Diagnostic by Segment

The study includes a forecast for the global helicobacter pylori diagnostic by type, technology, end use, and region.

Helicobacter Pylori Diagnostic Market by Type [Analysis by Value from 2018 to 2030]:

• Instruments
• Reagents
• Services

Helicobacter Pylori Diagnostic Market by Technology [Analysis by Value from 2018 to 2030]:

• Immunoassays
• POC
• Molecular Diagnostics

Helicobacter Pylori Diagnostic Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostics Laboratories
• Clinics

Helicobacter Pylori Diagnostic Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Helicobacter Pylori Diagnostic Market

In recent years, the Helicobacter pylori (H. pylori) diagnostic market has been growing rapidly, driven by increasing awareness of gastrointestinal problems and the rising incidence of H. pylori-related conditions globally. Diagnostic innovations, particularly non-invasive tests and molecular diagnostics, have significantly improved the ease of detection and increased the rate of identification of this bacterium. The market's expansion is also supported by regulatory approvals of new diagnostic devices and increased collaboration among industry players. Regions such as the USA, China, Germany, India, and Japan are at the forefront of these trends, focusing on improving health indicators through advanced diagnostics.

• United States: The U.S. market has seen a breakthrough in H. pylori diagnostics with the introduction of non-invasive methods, especially polymerase chain reaction (PCR)-based techniques that target specific gene sequences to detect the presence of H. pylori DNA in bronchoalveolar lavage fluid (BALF). Breath and stool antigen tests have gained popularity due to their fast turnaround times, which enhance patient satisfaction. Additionally, new trends in biomolecular diagnostic techniques have led to clearer and more accurate diagnostic criteria. Future market growth is expected to be driven by approvals for advanced diagnostic kits, as well as collaborations between diagnostic manufacturers and healthcare providers to improve screening practices.
• China: The H. pylori diagnostic market in China is growing rapidly, thanks to increasing health consciousness and improved healthcare facilities. The market also forecasts a rising demand for portable and efficient cellular infectious disease testing kits. The Chinese government supports gastrointestinal disorder prevention programs, which further boosts market growth. Companies like Nogoer are focusing on the development of rapidly marketable and functional diagnostic solutions tailored to the population's needs.
• Germany: Although competition in Germany for H. pylori diagnostic tests is intense, it has not deterred customers from making substantial investments, as the country remains a leader in adopting new diagnostic technologies. More physicians are incorporating rapid tests and advanced molecular diagnostic kits into their practices. Germany's market is highly regulated, meaning only the most reliable and rugged diagnostic tools are approved for use. High priority is placed on research into novel diagnostic methods through collaborations between universities and biopharmaceutical firms, which helps promote better detection and treatment of patients.
• India: The H. pylori diagnostic market in India is booming due to the rising incidence of gastrointestinal disorders. Growing investments in healthcare facilities are facilitating the adoption of newer technologies, such as rapid antigen tests and molecular diagnostics. These solutions must remain affordable to accommodate the diverse patient population. Additionally, government initiatives aimed at improving the understanding of H. pylori as a disease are enabling earlier diagnoses and treatments, thereby expanding the scope of the market.
• Japan: The H. pylori diagnostic market in Japan is highly competitive, with a strong focus on technology and research and development (R&D). The introduction of new technologies, such as breath tests, aims to enhance patient comfort without compromising diagnostic accuracy. Japanese manufacturers are developing next-generation diagnostic kits with more functionalities and ease of use. Collaborations with universities and research institutions play a key role in addressing the challenges of H. pylori populations as part of the broader national health strategy.

Features of the Global Helicobacter Pylori Diagnostic Market

Market Size Estimates: Helicobacter pylori diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Helicobacter pylori diagnostic market size by type, technology, end use, and region in terms of value ($B).

Regional Analysis: Helicobacter pylori diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, technology, end use, and regions for the helicobacter pylori diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the helicobacter pylori diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the helicobacter pylori diagnostic market by type (instruments, reagents, and services), technology (immunoassays, POC, and molecular diagnostics), end use (hospitals, diagnostics laboratories, and clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Helicobacter Pylori Diagnostic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Helicobacter Pylori Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Helicobacter Pylori Diagnostic Market by Type
  • 3.3.1: Instruments
  • 3.3.2: Reagents
  • 3.3.3: Services
• 3.4: Global Helicobacter Pylori Diagnostic Market by Technology
  • 3.4.1: Immunoassays
  • 3.4.2: POC
  • 3.4.3: Molecular Diagnostics
• 3.5: Global Helicobacter Pylori Diagnostic Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Diagnostics Laboratories
  • 3.5.3: Clinics

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Helicobacter Pylori Diagnostic Market by Region
• 4.2: North American Helicobacter Pylori Diagnostic Market
  • 4.2.1: North American Market by Type: Instruments, Reagents, and Services
  • 4.2.2: North American Market by End Use: Hospitals, Diagnostics Laboratories, and Clinics
• 4.3: European Helicobacter Pylori Diagnostic Market
  • 4.3.1: European Market by Type: Instruments, Reagents, and Services
  • 4.3.2: European Market by End Use: Hospitals, Diagnostics Laboratories, and Clinics
• 4.4: APAC Helicobacter Pylori Diagnostic Market
  • 4.4.1: APAC Market by Type: Instruments, Reagents, and Services
  • 4.4.2: APAC Market by End Use: Hospitals, Diagnostics Laboratories, and Clinics
• 4.5: ROW Helicobacter Pylori Diagnostic Market
  • 4.5.1: ROW Market by Type: Instruments, Reagents, and Services
  • 4.5.2: ROW Market by End Use: Hospitals, Diagnostics Laboratories, and Clinics

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Helicobacter Pylori Diagnostic Market by Type
  • 6.1.2: Growth Opportunities for the Global Helicobacter Pylori Diagnostic Market by Technology
  • 6.1.3: Growth Opportunities for the Global Helicobacter Pylori Diagnostic Market by End Use
  • 6.1.4: Growth Opportunities for the Global Helicobacter Pylori Diagnostic Market by Region
• 6.2: Emerging Trends in the Global Helicobacter Pylori Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Helicobacter Pylori Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Helicobacter Pylori Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: Biohit
• 7.3: Quest Diagnostics
• 7.4: Meridian Bioscience
• 7.5: Bio-Rad Laboratories
• 7.6: Alpha Laboratories
• 7.7: F. Hoffmann-La Roche
• 7.8: Coris BioConcept
• 7.9: Certest Biotec
• 7.10: Epitope Diagnostics